ライフサイエンスコーパス: IVC

1 IVC blood contributed 40+/-16% to total systemic venous

2 IVC bypasses bioavailability barriers of oral ingestion,

3 IVC failed to detect one-third of the ospC genotypes det

4 IVC filter patients did not have reduced rates of postop

5 IVC filter use quartiles showed no variation in mortalit

6 IVC filters are increasingly being used as prophylaxis a

7 IVC involvement by hepatic malignancy does not necessari

8 IVC thrombi extracted from Def(++) mice were composed of

9 IVC was safe in patients and showed the possibility to p

10 IVC-IAGPNA is invariably associated with VR reduction du

11 IVC-IAGPNA was associated with VR reduction in all dogs

12 Using proteomics, we identified 377 IVC-associated proteins in yeast cells grown under stead

13 nt implantation of 85 stents in 22 IFV and 6 IVC.

14 Out of 653 IVC-drawn blood culture pairs, both vials were contamina

15 invasive procedures (272 BDTs, 129 PEGs, 71 IVC filters).

16 Conclusion An absorbable IVC filter can be safely deployed in swine and resorbs g

17 Eleven absorbable IVC filters made from polydioxanone suture were deployed

18 r atrial ganglionated plexus nerve activity (IVC-IAGPNA) is responsible for ventricular rate (VR) con

19 After IVC administration, findings were similar.

20 a around the IVC filter within 2 weeks after IVC filter deployment with residual microscopic fragment

21 Among IVC results, common ospC genotypes were overrepresented

22 (2 )cavography was judged to be adequate, an IVC filter was deployed.

23 ous thrombosis (DVT) with the presence of an IVC filter, accounting for type and timing of initiation

24 uma patients with vs without placement of an IVC filter, whether in the presence or absence of venous

25 Among 451 trauma patients with an IVC filter and 1343 matched controls without an IVC filt

26 Among patients with an IVC filter and matched controls, age, sex, race/ethnicit

27 of mortality in patients with vs without an IVC filter who survived more than 24 hours from the time

28 filter and 1343 matched controls without an IVC filter, the mean (SD) age was 47.4 (21.5) years.

29 1%, VmaxAo greater than or equal to 10%, and IVC greater than or equal to 8% had a sensitivity of 61%

30 Stenotic/obstructed IFV and IVC may be reconstructed using stents to re-establish ve

31 using a 20 Fr Flexiflow Inverta-PEG kit, and IVC filters were placed percutaneously under ultrasound

32 The LVIDs and IVC collapsibility were independent predictors for morta

33 Here, we report the comparison of MMF and IVC as induction treatment for active lupus nephritis in

34 significant differences between the MMF and IVC groups with regard to rates of adverse events, serio

35 ed at 2 cm from the hepatic vein outlet) and IVC (measured at the level of the hepatic ostium) is >2

36 ancient genomes from the Iranian plateau and IVC descend from different groups of hunter-gatherers wh

37 on, SVC blood is directed toward the RPA and IVC blood is directed toward the LPA.

38 PP, VmaxAo, SVC, and IVC could be measured in 78.5%, 78.0%, 99.6%, and 78.1%

39 y ablation in the isthmus between the TA and IVC (TI isthmus) terminated the tachycardia in all patie

40 eral cervical vagal nerve activity (VNA) and IVC-IAGPNA during baseline sinus rhythm and during pacin

41 st in using high-dose intravenous ascorbate (IVC) in treating this disease partially because of its l

42 f equal amounts of IVC and SVC blood because IVC contribution to total systemic venous return is smal

43 nd left VNA in the former 5 dogs and between IVC-IAGPNA and right VNA in the last dog.

44 There were good correlations between IVC-IAGPNA and left VNA in the former 5 dogs and between

45 estigate pharmacokinetic interaction between IVC and gemcitabine.

46 We then assessed relationships between IVC filter placement and complications within 30 days of

47 rformed in eight patients with BCS caused by IVC thrombosis.

48 erference to gemcitabine pharmacokinetics by IVC administration.

49 ten are obtained from intravenous catheters (IVC).

50 of chronic occlusion of inferior vena cava (IVC) and iliocaval confluence with angioplasty and stent

51 ntal finding of complete inferior vena cava (IVC) and obliteration.

52 K (1.5 nmol) through the inferior vena cava (IVC) and subsequently submerged in psiepsilonRACK (0.5 m

53 , and using the aorta or inferior vena cava (IVC) as the input function.

54 ameters of the aorta and inferior vena cava (IVC) at the top of L2 and the bottom of L4 and to measur

55 aturation pulse labeling inferior vena cava (IVC) blood (signal void), and (3) a presaturation pulse

56 /- 5.9, with an aorta-to-inferior vena cava (IVC) CNR of 69.7 +/- 43.9.

57 to remove a retrievable inferior vena cava (IVC) filter can cause severe complications with high tre

58 ntation of an absorbable inferior vena cava (IVC) filter in a swine model.

59 eparin and warfarin, and inferior vena cava (IVC) filter placement were not independent predictors of

60 c gastrostomy (PEG), and inferior vena cava (IVC) filter placement.

61 hip between prophylactic inferior vena cava (IVC) filter use, mortality, and VTE.

62 Inferior vena cava (IVC) filters are widely used for prevention of pulmonary

63 The use of inferior vena cava (IVC) filters for prevention of venous thromboembolism (V

64 The use of inferior vena cava (IVC) filters in this population has been increasing, des

65 the role of prophylactic inferior vena cava (IVC) filters to prevent PE.

66 oagulation, placement of inferior vena cava (IVC) filters, clinical outcomes, and comments regarding

67 es concerning the use of inferior vena cava (IVC) filters.

68 reentry (LLR) around the inferior vena cava (IVC) has been described recently.

69 ntrol) were implanted as inferior vena cava (IVC) interposition grafts in juvenile lambs.

70 Obstruction of the inferior vena cava (IVC) is infrequent, membranous obstruction of the IVC (M

71 mbotic propensity in the inferior vena cava (IVC) ligation model.

72 rich clots after partial inferior vena cava (IVC) ligation than those that formed in wild-type (WT) m

73 rmates underwent partial inferior vena cava (IVC) ligation to induce venous thrombosis.

74 f the venous flow in the inferior vena cava (IVC) of 14 Fontan patients and 11 normal controls using

75 cular extension into the inferior vena cava (IVC) or atrium were identified.

76 flow restriction in the inferior vena cava (IVC) results in the development of thrombi structurally

77 ng a murine DVT model of inferior vena cava (IVC) stenosis, we demonstrate that mice with general ind

78 Inferior vena cava (IVC) thrombosis is generally a contraindication to renal

79 ic iliofemoral (I-F) and inferior vena cava (IVC) thrombosis.

80 iated with renal vein or inferior vena cava (IVC) thrombus in up to 10% of cases.

81 PV access from the inferior vena cava (IVC) to the main PV was performed in eight pigs by using

82 occlusion involving the inferior vena cava (IVC) treated by a portal decompressive procedure that by

83 suggested for the use of inferior vena cava (IVC) value instead of FHVP to calculate HVPG when the di

84 vein, hepatic veins, and inferior vena cava (IVC) were evaluated for thrombosis or stenosis by two ra

85 e hepatic segment of the inferior vena cava (IVC) were the vascular anomalies.

86 e of the mouse aorta and inferior vena cava (IVC), not restricting our analysis to the endothelium, t

87 nd reconstruction of the inferior vena cava (IVC), were reviewed.

88 Ten inferior vena cava (IVC)-SMV punctures were performed in six pigs.

89 with extension into the inferior vena cava (IVC).

90 ofemoral veins (IFV) and inferior vena cava (IVC).

91 segment of retrohepatic inferior vena cava (IVC).

92 hepatic and suprahepatic inferior vena cava (IVC).

93 dices, more collapsible inferior vena cavae (IVC), and higher heart rates than survivors.

94 four dogs before and during inferior caval (IVC) occlusion at five different inotropic stages and 14

95 pressure catheters and inferior vena caval (IVC) occluders; four had placement of thoracic aortic ba

96 venous (HV), subhepatic inferior vena caval (IVC), and portal venous (PV) flow rates were measured wi

97 ted initially with intravenous chemotherapy (IVC) and followed up for at least 1 year from last treat

98 ed previously with intravenous chemotherapy (IVC).

99 years; age range, 15-77 years) with chronic IVC occlusions were treated during a 6-year period.

100 t genome from the Indus Valley Civilization (IVC).

101 elles-called intracellular vesicle clusters (IVCs)-serve as sites for the synthesis of proteins targe

102 In vitro compartmentalisation (IVC), a technique for selecting genes encoding enzymes b

103 mulsion-based in vitro compartmentalization (IVC) method to select RBPs with defined specificity.

104 mulsion-based in vitro compartmentalization (IVC) to devise a method for the selection of zinc finger

105 phenotype by in vitro compartmentalization (IVC) using water-in-oil emulsions.

106 dwell times are associated with complicated IVC filter retrieval.

107 ue velocities during isovolumic contraction (IVC) (peak positive and peak negative), ejection (S) and

108 V deformation during isovolumic contraction (IVC) and isovolumic relaxation (IVR) might represent a t

109 feri in the tick vector by in vitro culture (IVC) and direct PCR (dPCR) were compared.

110 dvantages over intravenous cyclophosphamide (IVC) for the treatment of lupus nephritis, but these the

111 alent to intravenous pulse cyclophosphamide (IVC) for the induction treatment of lupus nephritis.

112 ardiography, of inferior vena cava diameter (IVC) measured using transthoracic echocardiography, of t

113 Differential IVC (the difference between peak positive and peak negat

114 lare after induction treatment with low-dose IVC.

115 and venous anomalies, and 1 had a duplicated IVC draining the left renal vein.

116 During IVC, flow from the LV apex accelerated toward the base,

117 tal cancer fixed to critical structures (eg, IVC and pelvic sidewall) are considered locally "unresec

118 114 patients who presented with tip-embedded IVC filters for removal from January 2005 to April 2014.

119 fully retrieve 109 of 114 (96%) tip-embedded IVC filters on an intention-to-treat basis.

120 ue can be safely used to remove tip-embedded IVC filters.

121 Successful I-F (+/-IVC) stenting in limbs with venous outflow obstruction a

122 IQR, 3-11.8 months) after successful I-F (+/-IVC) stenting, venous outflow (OF1, OF4) and calf muscle

123 ion) for chronic obliteration of the I-F (+/-IVC) trunks, on the venous hemodynamics of the limb, the

124 d with the control group, limbs with I-F +/- IVC thrombosis before stenting had reduced venous outflo

125 limbs to those stented without prior I-F +/- IVC thrombosis, nor infrainguinal clots on duplex, were

126 A total of 285 (75%) patients had an FHVP-IVC difference within +/-2 mm Hg (no discrepancy) and 95

127 Following IVC (vincristine, etoposide, and carboplatin), adjuvant

128 48 hours following IVC ligation, IVC thrombosis was evident in 60% of WT mi

129 For IVC-drawn blood cultures, some authorities recommend dis

130 2 )cavograms were obtained and evaluated for IVC diameter, location of renal veins, and presence of t

131 raction out of the IVC or open incisions for IVC management after laparoscopic dissection.

132 or in cells lacking VID genes, required for IVC formation.

133 to completely intracorporeal techniques for IVC tumor thrombectomy from incremental advancements in

134 and CAS in patients with BCS resulting from IVC occlusion.

135 of blood when obtaining blood cultures from IVCs does not reduce CR.

136 nching) and a decrease in expression of GnTs IVC and V (promote N-glycan branching) as detected by re

137 es, supragranular (layers II-IVB), granular (IVC), and infragranular (V-VI), across the entirety of V

138 Successful MR imaging-guided IVC-SMV punctures were performed in all 10 procedures (1

139 Twelve patients had IVCs that remained patent after a mean follow-up of 19 m

140 rcinoma cells exhibited significantly higher IVC clot weights, a biological readout of venous thrombo

141 ut-off value for HVPG-Free, but not for HVPG-IVC, among which 25 patients (26%) were misclassified re

142 ent, WHVP-FHVP (HVPG-Free) or WHVP-IVC (HVPG-IVC), better correlates with orthotopic liver transplant

143 tly of being calculated as HVPG-Free or HVPG-IVC.

144 /-5 mm Hg) was significantly lower than HVPG-IVC (17+/-5.5 mm Hg; P<0.001).

145 To determine if IVC filter insertion in trauma patients affects overall

146 l heart defects and stenotic or occluded IFV/IVC may encounter femoral venous access problems during

147 Infrahepatic IVC and portal venous blood flow were shunted to the axi

148 The infrarenal IVC, lungs, heart, liver, kidneys, and spleen were harve

149 espiration in the upper part of intrahepatic IVC proximal to a large collateral vein as well as prost

150 Isolated IVCs exhibited protein synthesis activities that require

151 in synthesis in intact cells and on isolated IVCs.

152 d 431 newly synthesized proteins on isolated IVCs.

153 ffered among various laminae; 2) layers IVA, IVC, and VI, which had high CO activity, were labeled mo

154 Changes occurring in layer IVC may influence the formation of heteromers and protec

155 a and -beta mRNA and protein levels in layer IVC of area 17 are subject to activity-dependent regulat

156 It was highly expressed in layers IVC and VI, which contained high levels of CO, and more

157 48 hours following IVC ligation, IVC thrombosis was evident in 60% of WT mice and 25% of

158 We report a case of membranous IVC obstruction at the junction of hepatic and suprahepa

159 ow levels or were undetectable in the murine IVC.

160 TEVG resembled the native IVC histologically and had comparable collagen (157.9 +/

161 Nevertheless, the main driving force of net IVC flow was the heart beat and not respiration.

162 led studies compared the effectiveness of no IVC filter vs IVC filter on PE, fatal PE, deep vein thro

163 eal space up to the level of the obliterated IVC, a collateral venous branch was identified at the co

164 ssive procedure that bypassed the obstructed IVC; and the third group, who had advanced cirrhosis and

165 and stent placement in chronically occluded IVCs has a good intermediate-term outcome and should be

166 f SVC blood flowed into the RPA, 67+/-12% of IVC blood flowed toward the LPA.

167 LPA blood is composed of equal amounts of IVC and SVC blood because IVC contribution to total syst

168 Analysis of IVC thrombosis revealed greater thrombus weight, length,

169 dence is low but supports the association of IVC filter placement with a lower incidence of PE and fa

170 ce to suggest that the potential benefits of IVC filters outweigh the significant risks of therapy.

171 MOIVC is a rare cause of IVC obstruction with typical radiological features.

172 ed data reporting the safety and efficacy of IVC filter use in bariatric surgical patients is highly

173 larger definitive trials testing efficacy of IVC in treating advanced pancreatic cancer.

174 Results There was no evidence of IVC thrombosis, device migration, caval penetration, or

175 Laparoscopic management of IVC tumor thrombi has been demonstrated in animal models

176 ear-old patient with iatrogenic occlusion of IVC following L3/L4 discectomy.

177 Iatrogenic permanent occlusion of IVC was successfully treated with recanalization and imp

178 The prevalence of prophylactic placement of IVC filters has increased among trauma patients.

179 lated and hospitals placed into quartiles of IVC filter use.

180 Risk-adjusted rates of IVC filter placement were calculated and hospitals place

181 iability (0.6% to 9.6%) in adjusted rates of IVC filter utilization.

182 Rates of IVC placement within quartiles were 0.7%, 1.3%, 2.1%, an

183 ation rates (CR), we assessed the results of IVC-drawn blood cultures for adults.

184 eview board-approved retrospective review of IVC filter retrievals between January 2002 and July 2011

185 lished reports on the efficacy and safety of IVC filters.

186 , exist regarding the efficacy and safety of IVC filters.

187 spective controlled observational studies of IVC filters versus none in patients at risk of PE.

188 f SVC was significantly greater than that of IVC (P = 0.02) and PP (P = 0.01).

189 ombosis or pulmonary embolism at the time of IVC filter placement.

190 The use of IVC filters for gastric bypass patients varied widely ac

191 We aim to review the evidence for the use of IVC filters in bariatric surgical patients, describe tre

192 een a number of studies reviewing the use of IVC filters in select populations for the prophylactic p

193 The use of IVC filters in this population should be reexamined beca

194 Overall, the use of IVC filters, especially in prophylactic situations, will

195 The use of IVC increases the degree of confidence in a novel radiol

196 ide important insights into the functions of IVCs as sites for the synthesis of EV-associated protein

197 The respiratory influence on IVC flow was the same in all groups.

198 The induction of 103Q-GFP on IVCs adversely affected total protein synthesis in intac

199 bolic disease with either anticoagulation or IVC filters.

200 s to open-label MMF (target dosage 3 g/d) or IVC (0.5 to 1.0 g/m(2) in monthly pulses) in a 24-wk ind

201 oscopy performed two hours following partial IVC ligation revealed that leukocyte firm attachment was

202 patch angioplasty, resulting in a permanent IVC occlusion, as confirmed by angiography.

203 During ischemia, positive IVC velocity was zero in ischemic walls with TEN >20%.

204 At reperfusion, positive IVC velocity correlated better with TEN (r = -0.94, p <

205 we report the development of radiopaque PPDO IVC filters based on gold nanoparticles (AuNPs).

206 uced PE-related mortality after preoperative IVC filter insertion.

207 l of 497 patients who underwent preoperative IVC filter insertion demonstrated DVT rates of 0% to 20.

208 ypass patients (8.5%) underwent preoperative IVC filter placement, most of whom (65%) had no history

209 Prophylactic IVC filters for gastric bypass surgery do not reduce the

210 A prophylactic IVC filter was placed in 803 (2%) of 39,456 patients.

211 rophylaxis and patient factors, prophylactic IVC filter placement was associated with an increased in

212 High rates of prophylactic IVC filter placement have no effect on reducing trauma p

213 data on the overall efficacy of prophylactic IVC filters with regard to outcomes.

214 nding and descending aortic flows (Q(SVC), Q(IVC), Q(PA), Q(PV), Q(Ao), and Q(Dao), respectively), bo

215 <9, hospitalization <3 days, or who received IVC filter after occurrence of VTE event.

216 Overall, patients receiving IVC filters had lower risk for subsequent PE (OR: 0.50;

217 be a good candidate material for resorbable IVC filters.

218 We review the literature on robotic IVC surgery.

219 (stage IVA: >50%, stage IVB: 30%-50%, stage IVC: <30%).

220 8 (95% confidence interval 1.50-1.67), stage IVC vs IVA: HR 3.54 (95% confidence interval 3.33-3.77)]

221 d (stages III and IVB), or metastatic (stage IVC).

222 , or metastatic (equivalent to primary stage IVC).

223 icantly increased in all patients with stage IVC disease.

224 d sex-matched control subjects with standard IVC filter retrieval were used for comparison.

225 = 1) or occlusion (n = 2), and suprahepatic IVC stenosis (n = 1).

226 y subtracting infrahepatic from suprahepatic IVC flow and PV flow from estimated TLBF, respectively.

227 SVC had a greater diagnostic accuracy than IVC and PP, but its measurement requires transesophageal

228 The IVC filter complication rate remains low; however, so do

229 The IVC was reconstructed with ringed Gore-Tex tube graft (n

230 The IVC-to-aorta venous-to-arterial enhancement ratio averag

231 enriched in aorta over other tissues and the IVC.

232 monstrated neointimal hyperplasia around the IVC filter within 2 weeks after IVC filter deployment wi

233 involving the lower right atrium around the IVC in 7 patients, figure-of-8 double-loop reentry aroun

234 supported by a reentrant circuit around the IVC or a figure-of-8 double-loop reentry involving both

235 ed with reduced platelet accumulation at the IVC wall after 6 hours of stenosis.

236 TIVCC was produced by banding the IVC for 10 days in 7 dogs, whereas in the 6 control dogs

237 ure-of-8 double-loop reentry around both the IVC and TA in 4, and single reentrant loop around the TA

238 -of-8 double-loop reentry involving both the IVC and TA.

239 biquitous in northwest South Asia during the IVC as it is today.

240 asionally combined with open surgery for the IVC control aspect of the procedure.

241 For the IVC, a mean of 72% was in the L2-L4 ROI.

242 ith these findings, the endothelium from the IVC of xenograft-bearing animals revealed nuclear AHR an

243 le to successfully puncture the SMV from the IVC with direct visualization of the needle and all retr

244 4% and 31+/-17%, respectively, came from the IVC.

245 rrelated positively with the increase in the IVC clot size.

246 The Iranian-related ancestry in the IVC derives from a lineage leading to early Iranian farm

247 nine deaths in the MMF group and five in the IVC group.

248 hildren in the atrial group and 17.2% in the IVC group.

249 The level of podoplanin in the IVC increased after 48 hours of stenosis to a substantia

250 e suture were deployed via a catheter in the IVC of 11 swine.

251 and venous development when implanted in the IVC of a juvenile lamb model.

252 Podoplanin was expressed in the IVC wall, where it was localized in the vicinity of the

253 r partial (stenosis) flow restriction in the IVC.

254 -F femoral vein sheath and advanced into the IVC by using a real-time gradient-recalled-echo sequence

255 fracture, filter tip incorporation into the IVC wall, and retrieval failure.

256 is infrequent, membranous obstruction of the IVC (MOIVC) being one of its rare causes.

257 PAI-1 expression in endothelial cells of the IVC and reduced clot weights in both kynurenine-injected

258 Use of the IVC as the input function resulted in significantly high

259 More than half (57%) of the IVC filter patients in the latter group had a fatal pulm

260 Eight percent (38 of 451) of the IVC filters were removed at Boston Medical Center during

261 hand-assisted thrombus retraction out of the IVC or open incisions for IVC management after laparosco

262 p or hook of the filter from the wall of the IVC.

263 ism or complications directly related to the IVC filter itself, including filter migration or thrombo

264 /16 of these had thrombosis extending to the IVC.

265 the main PV to be in direct contact with the IVC in all animals.

266 reduction only when it coactivates with the IVC-IAGPNA.

267 kmenistan in cultural communication with the IVC.

268 We present proof-of-principle for this IVC selection method by selecting a specific high-affini

269 cult and the complications of the thrombosed IVC may compromise life.

270 with end-stage renal disease and thrombosed IVCs were reviewed.

271 ed to MMF compared with 98 (53.0%) of 185 to IVC.

272 EDP decreased significantly from baseline to IVC occlusion (both p < 0.001).

273 went catheter-directed thrombolysis prior to IVC recanalization.

274 bjective of showing that MMF was superior to IVC as induction treatment for lupus nephritis.

275 ohort studies suggest that those who undergo IVC filter insertion preoperatively may be at higher ris

276 population similar to patients who underwent IVC filter insertion at Boston Medical Center (a level I

277 The interobserver correlation using IVC was excellent (0.97), but weak without IVC (0.52).

278 to enable selection of other proteins using IVC.

279 rdium, and site and size of the great veins (IVC and SVC).

280 The wall of the ventral IVC was ruptured during the operation.

281 mpared the effectiveness of no IVC filter vs IVC filter on PE, fatal PE, deep vein thrombosis, and/or

282 tically higher in wild-type than in VWF(-/-) IVC.

283 The level of extension was IVC in 134 and atrium in 31.

284 nable to identify any patient group for whom IVC filters were associated with improved outcomes.

285 hich gradient, WHVP-FHVP (HVPG-Free) or WHVP-IVC (HVPG-IVC), better correlates with orthotopic liver

286 re accurate in assessing prognosis than WHVP-IVC, HVPG should be calculated as the gradient between W

287 nd fatal PE (0.09 [0.01-0.81]; I(2)=0%) with IVC filter placement, without any statistical heterogene

288 e had received preoperative therapy (55 with IVC extension and 14 with atrial extension) for a median

289 enough to outweigh the harms associated with IVC filter placement remains unclear.

290 tter quality of life for small children with IVC thrombosis during an age when dialysis treatment is

291 fter multimodality treatments initiated with IVC, 50% of salvaged Group D retinoblastoma eyes had <20

292 otein as large puncta that co-localized with IVC markers, including fructose-1,6-bisphosphatase (FBPa

293 rted experiences of robotic nephrectomy with IVC tumor thrombectomy, thus far, demonstrate feasibilit

294 gradient between WHVP and FHVP, but not with IVC, in order to optimize its prognostic value and in id

295 cardiographic follow-up in two patients with IVC stents demonstrated wide patency.

296 ded to treat to prevent 1 additional PE with IVC filters is estimated to range from 109 (95% CI, 93-1

297 ithout IVC (p = 0.004) and in protocols with IVC (p = 0.002).

298 Neuroradiologist without IVC found 82.5% of extraotic pathology and 17.5% of otic

299 dings in the ears, both in protocols without IVC (p = 0.004) and in protocols with IVC (p = 0.002).

300 g IVC was excellent (0.97), but weak without IVC (0.52).